With novel therapies on the way, ‘the outlook is bright’ in lupus

Novel therapies may allow more patients with lupus to reach remission or low disease activity, according to a presenter at the AWIR annual conference.“Although there has been significant improvement in outcomes for patients with lupus over time, we are still witnessing excessive morbidity and mortality,” Richard A. Furie, MD, chief of the division of rheumatology at Northwell Health,